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Abstract
Background: Given evidence shows physical activity, a healthful diet and weight management can improve cancer
outcomes and reduce chronic disease risk, the major cancer organisations and health authorities have endorsed
related guidelines for cancer survivors. Despite these, and a growing evidence base on effective lifestyle
interventions, there is limited uptake into survivorship care.
Methods/Design: Healthy Living after Cancer (HLaC) is a national dissemination and implementation study that will
evaluate the integration of an evidence-based lifestyle intervention for cancer survivors into an existing telephone
cancer information and support service delivered by Australian state-based Cancer Councils. Eligible participants
(adults having completed cancer treatment with curative intent) will receive 12 health coaching calls over 6 months
from Cancer Council nurses/allied health professionals targeting national guidelines for physical activity, healthy eating
and weight control. Using the RE-AIM evaluation framework, primary outcomes are service-level indicators of program
reach, adoption, implementation/costs and maintenance, with secondary (effectiveness) outcomes of patient-reported
anthropometric, behavioural and psychosocial variables collected at pre- and post-program completion. The total
participant accrual target across four participating Cancer Councils is 900 over 3 years.
Discussion: The national scope of the project and broad inclusion of cancer survivors, alongside evaluation of
service-level indicators, associated costs and patient-reported outcomes, will provide the necessary practice-based
evidence needed to inform future allocation of resources to support healthy living among cancer survivors.
Trial registration: Australian and New Zealand Clinical Trials Registry (ANZCTR) - ACTRN12615000882527
(registered on 24/08/2015)
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Background
Cancer survivorship in Australia
Five-year survival rates for the majority of cancers have
steadily improved in Australia over the past decades,
from 47 % to 66 % between the periods 1982–1987 and
2006–2010, with rates for the most prevalent cancers -
prostate, breast and colorectal cancers - now being 92 %,
89 % and 66 %, respectively [1, 2]. These improvements
in survival are also mirrored across other developed
countries [3]. However, cancer survivorship brings with
it increased risk of cancer recurrence, second primaries,
persistent side-effects of treatment, functional decline
and co-morbid chronic conditions, such as cardiovascu-
lar disease and type 2 diabetes [4–7]. To mitigate these
risks and improve the longer-term well-being of cancer
survivors, national cancer organisations recommend that
cancer survivors engage in regular physical activity, eat a
healthy diet and keep their weight within a healthy range
[8–10]. Yet, the majority of cancer survivors do not meet
these lifestyle recommendations; over 50 % are over-
weight or obese, over 50 % do not meet physical activity
recommendations, and 90 % do not meet dietary guide-
lines [11–13]. Further, declines in activity and weight
gain are common post-cancer treatment [14–16]. Des-
pite a strong desire on the part of most cancer survivors
for advice and support regarding healthy lifestyles [17],
such assistance is not routinely offered as part of
survivorship care [17–19].
Lifestyle interventions for cancer survivors
Initial research in lifestyle interventions in cancer survi-
vors emphasised efficacy trials of highly selected partici-
pants (primarily women with early stage breast cancer),
with strictly controlled intervention protocols delivered
in supervised, clinic settings [20–25]. Over the past
decade, the number of trials of lifestyle interventions in
cancer survivor groups other than breast has expanded,
demonstrating their safety, feasibility and efficacy in
gynaecological cancers, prostate, colorectal, and lung can-
cers [26–42]. With the efficacy of such interventions, par-
ticularly for physical activity, firmly established [43–45],
the emphasis has shifted to effectiveness or pragmatic
trials designed to answer questions important to in-
forming translation into routine practice (How do we
reach the growing number of cancer survivors, many of
whom live outside of metropolitan areas? Which health
care providers are best suited to deliver lifestyle interven-
tions, and what are the resources required for intervention
delivery? Are post-intervention improvements in patient-
reported outcomes maintained or are booster sessions
needed?) [46–49].
A particular area of interest has been the evaluation of
broad-reach or distance intervention modalities, particu-
larly the telephone, as this mode of delivery has the
potential for far greater reach compared to face-to-face
delivered interventions [32, 34, 35]. A recent systematic
review of 27 trials of broad-reach lifestyle interventions
among cancer survivors (22 of them telephone-
delivered) found evidence for improvements in lifestyle
behaviours and weight loss across cancer survivor
groups [50]. In a comparative-effectiveness trial of an
exercise intervention for women during and after treat-
ment for breast cancer, a telephone-delivered inter-
vention was as effective as a face-to-face-delivered
intervention for achieving improvements in fitness and
quality of life [51, 52] and suitable for reaching women
living in regional and rural Australia [53]. This now large
body of evidence on the efficacy and effectiveness of
lifestyle interventions among diverse cancer survivors,
including evidence for the effectiveness of telephone
delivery, sets the stage for the present study and a future
mechanism of routine support for cancer survivors.
The Healthy Living after Cancer partnership
Healthy Living after Cancer (HLaC) is a dissemination
and implementation study that will evaluate the in-
tegration of an evidence-based lifestyle intervention for
cancer survivors into an existing telephone cancer infor-
mation and support service delivered by the Australian
state-based Cancer Councils. Outcomes, as described in
detail below, are service-level and consumer/patient-
reported.
In Australia, the Cancer Councils are non-governmental,
not-for-profit, cancer control organisations located in each
state and territory that deliver programs and provide in-
formation and support across the cancer continuum from
cancer prevention through to cancer survivorship. They
also fund as well as conduct research. The Cancer
Councils offer a telephone “13 11 20 Cancer Information
and Support Service” (previously known as the Helpline)
with coverage across Australia. This existing service deliv-
ery infrastructure, combined with the priority placed on
survivorship support, and their position stand on nutrition
and physical activity for cancer survivors [9], provide an
optimal framework on which to scale-up, implement
nationally and evaluate an evidence-based lifestyle inter-
vention for cancer survivors.
The five largest Cancer Councils were approached for
collaboration, with four agreeing to take part (Cancer
Councils New South Wales, Victoria, South Australia
and Western Australia). The Australian National Health
and Medical Research Council Partnership Projects
scheme, which is designed to support academic-industry
research partnerships leading to translation of results
into health policy and practice [54], was targeted for
funding. A concept development workshop was orga-
nised to engage cancer policy and practice stakeholders,
including the Cancer Councils, along with national and
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international lifestyle and cancer survivorship experts
and clinicians (co-authors on this paper). The workshop
was sponsored by two Australian Cancer Trials Groups,
which led to the development of a funding proposal, and
the subsequent collaboration that now governs the
Healthy Living after Cancer Partnership Project.
The five-year study will be conducted in three phases:
Phase 1 involves knowledge transfer and capacity build-
ing (Year 1). In this phase, the research team will work
closely with Cancer Council partners to facilitate their
ability to implement and evaluate HLaC, including data-
base adaptations, staff training and input from Cancer
Council staff on program materials. Phase 2 involves
HLaC implementation and evaluation (Years 2–5), with
intervention procedures and the evaluation plan de-
scribed below. Phase 3 involves advocacy within the
Cancer Councils, alongside communication of HLaC
outcomes to the broader cancer control community and
health care sector, in an effort to obtain sustained fund-
ing for the program (Years 4–5).
Methods/Design
Study design
The HLaC dissemination and implementation study uses
a single-group, pre-post-test study design. The research
questions to be answered are those important to inform-
ing translation into practice, particularly the feasibility
and costs associated with wide-scale program implemen-
tation [46, 55] and the cancer survivor outcomes that
can be achieved in the health services delivery context.
Accordingly, the RE-AIM Framework (reach, effective-
ness, adoption, implementation, maintenance) [56] is
used to guide systematic evaluation, with assessment of: the
reach of the intervention (i.e., the number and representa-
tiveness of service referrers and participants/consumers);
program implementation (i.e., number of referrals, con-
sent rates, fidelity of delivery, program completion rates
and costs to deliver); effectiveness (i.e., cancer survivor
outcomes including behavioural, anthropometric and
psychosocial variables); and maintenance (i.e., the capacity
of the Cancer Councils to continue to deliver the service
following the end of this study). Ethical approval was
granted from the human research ethics committees of
the following institutions: Cancer Council Victoria (on
behalf of Cancer Councils Victoria and South Australia),
Cancer Council New South Wales, the University of
Queensland and the University of Western Australia
(on behalf of Cancer Council Western Australia). Ethical
approval is also sought as required for referring clinical
sites in these states.
Participants and referral pathways
The HLaC program is targeted to any adult cancer sur-
vivor who has been treated with curative intent and who
has completed treatment. Referral pathways for poten-
tially eligible participants fall under three broad head-
ings: Cancer Council services and programs (e.g., the 13
11 20 information and support service; survivorship
support and education programs); Cancer Council net-
works and partners (e.g., Prostate Cancer Foundation of
Australia; Breast Cancer Network Australia); and cancer
treatment sites (e.g., metropolitan and regional hospitals).
Within these categories, each Cancer Council will de-
velop, in conjunction with the research team, its own
HLaC referral pathways based on local knowledge and
with a study-wide agreed emphasis on outreach to non-
urban areas in which 30 % of Australian cancer survivors
reside [57].
Cancer Council staff will provide representatives at each
referring organisation or site with information about the
HLaC program (a referrer information sheet), along with
promotional material (posters and brochures), and will be
encouraged to recommend the program to any potentially
interested and eligible patients and cancer survivors.
Based on varying ethics requirements across sites, at
some, interested patients will give verbal consent for their
name and contact details to be forwarded to their local
Cancer Council so that HLaC project staff may telephone
them to discuss the program in more depth (including
screening for eligibility). At other sites, interested patients
will be given a referral form to return to their Cancer
Council. Interested cancer survivors may also self-refer by
telephoning 13 11 20 and enquiring directly about the
program at any time, as advertised on the promotional
posters and brochures.
Accrual targets
The overarching aim is for each Cancer Council to deliver
the program over a three-year period. This should afford
adequate experience with program implementation and
familiarity with outcomes to inform decisions on program
sustainability. Accrual targets for each Cancer Council are
based on available resources to implement the program.
There is capacity for each participating Cancer Council to
achieve approximately 50–60 program completions/year
implementing the HLaC program 6-month/12 call
protocol (refer to the program delivery section). With an
estimated 30 % attrition, each Cancer Council would
therefore need to enrol approximately 75–80 partici-
pants per year. The attrition estimate is based on the high
(nearly 50 %) attrition observed in other disseminated
lifestyle intervention programs in the general adult
population [58, 59], but tempered by the fact that cancer
survivors tend to be highly motivated such that cancer-
specific trials generally achieve 90 % 12-month retention
[32, 35, 52, 53, 60]. Across the three years of HLaC
implementation, it is anticipated that each Cancer Council
will achieve completion rates of approximately 150–180
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participants, for a total of approximately 600–680 HLaC
completing (from 900 enrolled) during the proposed study
(refer to the sample size section).
Screening and consent
The eligibility criteria for the HLaC program are designed
to be as broad as possible, thereby maximising the diver-
sity of survivors who are able to take part and ensuring
participants are able to do so safely. The eligibility criteria
are: adults (18+ years); diagnosed with localised (i.e., non-
metastatic) cancer of any type treated with curative intent;
completed primary treatment (i.e., surgery, chemotherapy,
radiation; patients currently receiving hormonal treatment
or Herceptin are still eligible); no contraindications to
engaging in unsupervised physical activity (i.e., active heart
disease, breathing problems requiring hospitalisation in
the past 6 months, undergoing dialysis, diabetic complica-
tions such as severe neuropathy or retinopathy, planning a
knee or hip replacement in the next six months, preg-
nant); no cognitive or mental health impairments that
would hinder program participation; able to speak and
read English sufficiently to allow for program participa-
tion; wanting support for healthy living via physical activ-
ity and healthy eating and willing to make a six-month
commitment to HLaC program participation. Screening
will occur over the telephone by Cancer Council staff uti-
lising a recruitment and screening script, with eligibility
based on patient self-report (Table 1). In cases where eligi-
bility is uncertain, the patient will be asked to seek permis-
sion to take part from their treating clinician and report
back to Cancer Council staff, with the outcome recorded
in the database. Those eligible will be posted an informa-
tion sheet and a follow-up telephone call will be com-
pleted a week later to obtain informed consent (verbal and
audiotaped or paper-based, depending upon the recruit-
ment protocol used at the referring site).
Healthy Living after Cancer program
The six-month HLaC program is aimed at increasing
physical activity, promoting healthy eating, and assisting
with moderate weight loss (if indicated), consistent with
current evidence and guidelines for nutrition and
physical activity in cancer survivors (Table 2) [8–10].
Delivered by study-trained, Cancer Council nurses/allied
health professionals with expertise in cancer care, it will
provide the necessary support and advice to meet these
guidelines while dealing with common cancer survivor-
ship issues including lymphoedema, pain, fatigue and
fear of recurrence. Participants will receive up to 12 tele-
phone calls over the 6-month program along with a
HLaC Participant Workbook (Table 3) used to support
intervention delivery.
Cancer Council nurses/allied health professionals will
be trained in the HLaC protocol by study investigators.
A Training Manual detailing the intervention protocol,
including example call scripts, will be made available to
all trainees prior to a two-day, group-based training
workshop, which makes extensive use of role-playing.
Using a train-the-trainer approach, the training is video-
taped and a lead nurse from each Cancer Council will
take responsibility for the initial training of any new staff
requiring training during the study period. Within each
Cancer Council, those delivering the program will de-
brief weekly on participant progress with the lead HLaC
nurse, alongside email access to the research team for
support as needed and monthly case management tele-
conferences organised with the lead investigator.
Intervention delivery is grounded in Social Cognitive
Theory constructs of self-efficacy, social support and
outcome expectancies [61] and is guided by techniques
of motivational interviewing [62] and health behaviour
coaching [63]. The emphasis is on developing participant
skills in evidence-based behaviour change strategies –
goal setting, self-monitoring, problem solving, identifying
social support, stimulus control, positive self-talk and self-
reward [64]. The structured protocol for each call in-
cludes: assessment of progress; problem-solving; advice/
education; and collaborative (“SMART”) goal-setting/goal
progression (detailing a behaviourally-specific plan for
goal achievement).
Intervention procedures
A semi-structured approach to the order in which inter-
vention targets are addressed is used to guide delivery and
works in accordance with the Participant Workbook (see
Table 3). Participants are encouraged to begin with a focus
on increasing physical activity, as it is often more chal-
lenging to achieve than making small changes to dietary
intake. However, consistent with the motivational inter-
viewing approach, the intervention is tailored to each par-
ticipant, with an initial focus on targets in areas that the
participant is most motivated and confident to change.
The intervention is delivered in three phases, with weekly,
fortnightly and then monthly calls, as depicted in Table 4.
Physical activity
The physical activity component of the intervention fo-
cuses on identifying enjoyable activities that can be easily
incorporated into a participant’s lifestyle (e.g., walking),
with gradual increases in physical activity aimed at meet-
ing or exceeding the target of 30 minutes per day of
moderate-to-vigorous intensity activity daily. Resistance
exercise (2–3 sessions/week) is also encouraged, with
detailed photographs and instructions, guidelines on the
number of sets and repetitions of each exercise, and
options for progression, outlined in the Participant
Workbook. In addition to daily planned physical activity,
participants are encouraged to capitalise on opportunities
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to be active in and around their homes and workplaces
(e.g., gardening, housework, taking the stairs) [65–67] and
to reduce sitting time (i.e., to get up and move every
30 minutes and to aim for no more than 2 hours/day
of screen time outside of work) [68–70].
Diet and weight loss
All participants are encouraged to achieve three over-
arching dietary aims: 1) increasing intake of vegetables,
fruit and whole grains; 2) reducing intake of foods high
in added sugars and fat (especially saturated fats) and 3)
limiting portion size and improving dietary quality. In
addition, those who are overweight and want to work to-
wards modest weight loss (i.e., 5–10 % of initial body
weight) focus on reducing energy intake by 2,000 kJ per
day. Strategies to reduce energy intake include: improv-
ing portion control (by reducing portion size or number
of serves) and lowering energy density (by increasing
Table 1 Eligibility criteria and their associated screening questions
Eligibility criteria Screening question/s
Adults aged 18+ years • What is your date of birth (day, month and year)?
Diagnosed with localised potentially curative cancer of any type • When were you diagnosed with cancer (most recent diagnosis)?
Please tell me the day, month and year as best you can remember.
• What type of cancer were you diagnosed with?
• Was your cancer localised, or did it spread to other parts of your
body (i.e., were you diagnosed with metastatic disease or advanced
cancer)?
Completed treatment (i.e., surgery, chemotherapy, radiation; hormonal
treatment or Herceptin are fine)
• Have you completed treatment for cancer – i.e., surgery,
chemotherapy or radiation therapy? This does not include hormonal
treatment or Herceptin which you may still be on.
Without contraindications to engaging in unsupervised physical
activity
• Are you currently pregnant or lactating or intending to become
pregnant in the next 6 months?
• Do you currently use a walker or wheelchair regularly to help you
walk or move around? This does not include using a walking stick.
• Have you had any health problems, such as a stroke, or have you
had an accident, that has left you with walking difficulties?
• Do you have plans for a hip or knee replacement in the next
6 months?
• Do you ever feel any pain, tightness or heaviness in your chest either
when you are resting or when you are physically active?
• Have you been told by your doctor that you have a heart condition
and that you should only do physical activity supervised by a health
professional?
• Have you been told by your doctor that you’ve had a heart attack
within the last 6 months?
• Have you had any breathing problems that required hospitalisation
or oxygen use within the past 6 months?
• Do you have severe chronic lung disease?
• Do you take the blood thinners Warfarin, Coumadin or Marevan?
• Do you have moderate to severe kidney disease or are you
undergoing dialysis?
• Do you suffer from neuropathy or nerve damage, which is most
commonly caused by complications from diabetes?
• Do you suffer from retinopathy or damage to the retina in the eye,
most commonly caused by complications from diabetes?
Without cognitive or mental health impairments that would hinder
program participation
• Have you ever been diagnosed with depression/anxiety/any other
mental health condition?
• If yes, are you currently suffering from depression/anxiety/any other
mental health condition?
• If yes, is your depression/anxiety/any other mental health condition
currently stable and/or being managed by medication or treatment
from a health professional?
Able to speak and read English sufficiently to allow for program
participation
Assessed by staff during the screening call (i.e., is the person they
are screening able to understand the questions and respond
appropriately).
Wanting support for healthy living via exercise and healthy eating and
willing to make a six-month commitment to HLaC program
participation
Participants are asked to read the Participant Information Sheet and
consider whether now is a good time for them to take part in the
program before providing consent.
Table 2 Healthy Living after Cancer intervention targets
Maintain a healthy body weight (BMI between 18.5 – 24.9 kg/m2)
Engage in 30 minutes or more of moderate physical activity daily
Consume a low saturated fat diet, including 5 serves of vegetables and
2 serves of fruit daily
Eakin et al. BMC Cancer  (2015) 15:992 Page 5 of 11
intake of low energy dense foods such as fruits and vege-
tables and reducing intake of foods with high energy
density such as high fat/sugar foods).
Data collection
All study data are collected by study-trained Cancer
Council staff as this enables capacity building for
ongoing program evaluation. Study funding is used to
ensure that each Cancer Council has a dedicated
research assistant to support evaluation. Study protocol
implementation and data quality control are monitored
via weekly database reports submitted by Cancer
Council staff to the research team.
Primary and secondary outcomes
Outcomes are shown in Table 5, along with the relevant
RE-AIM indicators and measurement tools. Primary
(service-level) outcomes include referrals, call delivery,
completion rates, participant and staff satisfaction and
program delivery costs, and will be systematically
collected in each of the Cancer Council databases.
Secondary (anthropometric, behavioural and psychosocial)
outcomes are patient-reported during pre- and post-pro-
gram assessments conducted by Cancer Council staff
via telephone and using validated protocols and
questionnaires.
Statistical analyses
Primary outcomes for HLaC implementation will be re-
ported descriptively. Analyses of secondary (effectiveness)
outcomes will be by mixed models, which allow for re-
peated measures (baseline and follow-up) and will include
all participants with baseline data (including those with
missing data at follow-up) with adjustment for predictors
of dropouts to minimise non-response bias. Data will be
analysed collectively (pooled) across Cancer Councils as
well as reported individually for each. To minimise type I
errors because of testing multiple outcomes, significance
will be set at p < 0.001 (two-tailed). Sensitivity of conclu-
sions to missing data assumptions will be evaluated.
Sample size related to secondary (effectiveness)
outcomes
Given the resources available in each Cancer Council to
support HLaC implementation, the service delivery is
expected to provide a sample size of approximately 900
participants across the four participating Cancer
Councils over the three year recruitment period. This
sample provides >90 % power with two-tailed sig-
nificance of p < 0.001 to detect pre-post changes of
60 minutes of physical activity per week, 0.5 serves of
fruit or vegetables, 2 kg weight and clinically relevant
changes in physical and mental components of quality of
life (3 units each) [71], based on assumed standard devi-
ations of change of 300 min/week, 1.5 fruit and 2 vege-
table serves, 8 kg weight, and 8 units on the mental and
physical component scores. These calculations allow for
30 % participant attrition and adjustment for up to 10
covariates (10 observations per covariate).
Economic appraisal
The economic questions associated with this research
relate to the costs of implementing HLaC and the
relationship between costs, program completion and
outcomes. Specifically:
 Costs of implementing HLaC: The fixed costs
(i.e., expenditure required to deliver the HLaC
program, including resources associated with
modifying Cancer Council databases, refining
referral pathways, adapting the intervention and
evaluation protocols and recruiting and training
nurses) will be documented. Dollar values will be
attached to these resources using publicly
available information such as appropriate salary
rates for the time of personnel involved in the
above activities and commercial prices for the
production of any training materials, etc. Fixed
costs will be allocated equally over all participants
who consent to participate in HLaC. Variable
costs (i.e., those that are proportional to the
volume of service provided) will be allocated in
proportion to the stage of HLaC reached by
individuals [72].
Table 3 Healthy Living after Cancer Participant Workbook content
Introduction to Healthy Living after Cancer (Section 1)
• Importance of healthy living for cancer survivorship
Plan for Success (Section 2)
• Participant aims
• SMART goal setting
• Problem solving
• Tracking your progress
Physical Activity (Section 3)
• Aerobic activity (e.g., brisk walking)
• Flexibility/stretching
• Strength training
• Reducing sitting time
Healthy Eating (Section 4)
• Increasing serves of vegetables, fruit and wholegrains
• Reducing fat (particularly saturated fat) intake
• Eating the right amount of food (portion control)
• Choosing the right types of food (low calorie, high nutrient)
Weight Loss/Maintenance (Section 5)
• Setting an appropriate weight loss goal (5 % – 10 % of initial body weight)
• Strategies for achieving a 2000 kJ/day reduction
Staying on Track (Section 6)
• Positive thinking
• Getting back on track after a slip
• Planning ahead
• Getting support from others
• Celebrating success
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 Relationship between costs, completion and
outcomes: Stage of completion will be defined as
follows: Stage 1 = completion of ≥3 x weekly phone
calls; Stage 2 = completion of Stage 1 + ≥3 x fortnightly
phone calls; Stage 3 = completion of stages 1 + 2 + ≥3
monthly calls. For the purposes of the economic
appraisal, outcomes will be defined using a series of
pre-defined benchmarks based on pre-post program
changes in the behavioural and anthropometric
variables. For total physical activity, participants who
reported achieving 150 minutes/week are considered
as having made improvements in their physical
activity level. For vegetables and fruit, participants
who reported achieving the target of 5 and 2 serves/
day, respectively, are classified as having made positive
changes in their dietary behaviour. For weight
(among participants where weight loss is indicated),
those who recorded a body weight reduction at
follow-up ≥3 % of their baseline weight will be
classified as having successfully achieved a health
enhancing benefit [73]. Regression analysis will be
used to assess the relationship between completion of
stages and outcomes achieved. It is hypothesised that
those who complete Stage 3 will have better outcomes
than Stage 2 completers who in turn will have better
outcomes than those who do not proceed beyond
Stage 1. Pre- and post-test differences will be
calculated as changes in Quality of Life (SF-12) and
Quality Adjusted Life Years (QALYs) SF6D [74]
(calculated from SF-12). Data will be analysed with
and without imputed outcomes. Sensitivity analysis
will be used to explore the impact of varying
assumptions about the cut-offs used to define
improvements in the secondary outcomes noted above.
Discussion
This study represents the first scaled-up and national-
level implementation and evaluation of an evidence-based
lifestyle intervention for cancer survivors in collaboration
with a peak cancer control and community facing partner.
As such, it is consistent with calls for the conduct of
practice-based and dissemination research that accelerates
the transfer of cancer survivorship research into evidence-
based cancer care [47–49]. A participatory and collabora-
tive approach has been used to build both capacity
amongst Cancer Councils for program delivery and
evaluation and to ensure the collection of outcomes data
necessary to inform decisions about sustained funding.
Accordingly, from the outset, the study has engaged a
group of cancer policy, practice and service delivery stake-
holders, along with lifestyle and cancer survivorship
experts and cancer clinicians. This transdisciplinary col-
laboration provided guidance on study design, evaluation
and intervention protocol adaptation and will oversee
study implementation, culminating in consideration of
and advocacy around study findings in relation to sus-
tained funding for HLaC program delivery.
As a dissemination and implementation study there
are some inherent limitations. The use of a single group,
pre-post study design is primary among these. However,
the primary questions to be answered are about the
feasibility and costs of wide-scale implementation, and
the survivor outcomes that can be achieved in this con-
text. Numerous previous efficacy trials have answered
the question as to whether lifestyle intervention is super-
ior to usual care or no intervention [43–45, 75–77]. The
use of self-report measures of health behaviour changes
is a limitation [78, 79], however, all self-reported tools have
been validated, including against objective measurement
Table 4 Intervention phases, call frequency and call objectives
Phase Call frequency # Calls Purpose Objectives
Phase one Month 1 Weekly 1-4 Rapport-building, engagement,
education, skill-building
• Program overview
• Feedback on pre-program assessment to
build motivation to change
• Build engagement through homework and
self-monitoring
• Understand importance of physical activity,
healthy eating and healthy weight
• Understand and begin using behaviour
change skills: setting goals, tracking,
problem-solving, identifying benefits,
rewarding success
Phase two Months 2-3 Fortnightly 5-8 Putting it into practice • Progress goals
• Add new target behaviours
• Review progress, reinforce success, identify
benefits and problem-solve barriers
• Ongoing education
Phase three Months 4-6 Monthly 9-12 Consolidation and maintenance • Use of supports and strategies for
maintaining changes
• Shift to participant lead in progressing
goals and tracking behaviour
• Closure
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Table 5 Primary and secondary outcomes, assessment tools and RE-AIM indicators
Setting RE-AIM indicator Collection method/assessment tools
Primary Outcomes
Referring Sites Adoption & Maintenance
Type of referring site and # of referrals CC database
Staff satisfaction and feedback on sustainability of
referral protocol
Interview
Cancer Councils Reach & Representativeness
% uptake among eligible survivors CC database
Participant characteristics CC database
Implementation
Participant consent rates CC database
Completion rates CC database
Withdrawal rates and reasons CC database
Number of intervention calls CC database
Length of intervention calls CC database
Administration time for intervention calls CC database
Intervention content covered CC database
Completion of pre- and post-program assessments CC database
Adverse events CC database
Healthy Living after Cancer nurse/allied health
professional and CC manager satisfaction
Interview
Economic Appraisal
Costs to deliver the Healthy Living after Cancer
program
Documentation of resources utilised for Healthy Living




Weight, height, waist circumference Self-reported
Behavioural Outcomes
Physical Activity Active Australia Survey [83]
Sedentary Behaviour Single item from the International Physical Activity
Questionnaire (short, last 7 days format) [84]
Diet Fat and Fibre Behaviour Questionnaire [85]
Daily servings of fruits and vegetables [86]
Psychosocial Outcomes
Quality of Life Short-Form Health Survey (SF-12), v1.0 [87]
Cancer and treatment-related symptoms and
side-effects
MD Anderson Symptom Inventory [88]
Fear of Cancer Recurrence The Concerns about Recurrence Questionnaire – 4-item
(CARQ-4) [89]
Distress 2-item Distress Thermometer assessing distress
(adapted from the National Comprehensive Cancer
Network Distress Thermometer for Patients) [90] and
impact of distress [91]
Healthy Living after Cancer program satisfaction Self-reported (rating scales and comments)
CC Cancer Council
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where feasible [80–82], and have been used in cancer
samples, with the national scale of implementation and
resource limitations precluding collection of clinically-
assessed outcomes. The collection of data by Cancer
Council staff, some of whom will have a role in program
delivery, may be a source of bias. However, in this context,
it was felt that (i) the emphasis on building evaluation
capacity among the Cancer Council partners outweighed
any inherent bias and (ii) this protocol is more closely rep-
resentative of the real-world process of program delivery
and evaluation, with both important for supporting the
final phase of the project, specifically, advocating for
sustained HLaC delivery beyond the funding period.
It is important to note that the healthy living targets
being promoted in this study, and ratified by Cancer
Council Australia and the World Cancer Research Fund,
are based on general population recommendations for
cancer prevention [8–10]. And further, that the vast
majority of lifestyle intervention evidence among cancer
survivors has been conducted in healthier samples with
early (not advanced) cancers. Accordingly, the HLaC
study targets survivors treated with curative intent.
There is still more research needed to inform the safety,
feasibility and efficacy of lifestyle interventions for those
with advanced cancers, as well as understanding the
upper and lower thresholds for physical activity, dietary
change, and weight loss, and the optimal sequencing of
these multiple lifestyle intervention targets.
The HLaC study is national in scope, involving the
relevant cancer control stakeholders and multidisciplin-
ary expertise; is based on broad inclusion of cancer sur-
vivors; and includes an evaluation of both service-level
indicators and associated costs and cancer survivor
outcomes. The evidence to be generated from this collab-
orative study is what is directly required to influence health
policy and practice related to cancer survivorship care
around provision of support for healthy living after cancer.
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